MetGen Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Employees
  • 33
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $3.98M
Latest Deal Amount
  • Investors
  • 12

MetGen General Information

Description

Producer of novel enzymatic products intended to enhance the pre-treatment of a variety of lingo-cellulosic biomasses in an industry. The company's products utilize laccases or copper-containing oxidase enzymes which facilitate various oxidative functions and helps to accelerate chemical reactions, resulting in significant efficiency improvements in the pulp, paper, and biofuels industries, also in the removal of toxic micro-pollutants from wastewater, enabling clients to promote safe food, maintain clean environments, optimize water, energy use as well as improve operational efficiencies.

Contact Information

Website
www.metgen.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Industrial Chemicals
Other Industries
Environmental Services (B2B)
Specialty Chemicals
Primary Office
  • Rakentajantie 26
  • 20780 Kaarina
  • Finland
+358 02 0000000

MetGen Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MetGen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 23-Feb-2018 $3.98M 00.000 000.00 Completed Generating Revenue
7. Later Stage VC 22-Dec-2017 00.000 Completed Generating Revenue
6. Later Stage VC 15-Sep-2017 00000 00.000 Completed Generating Revenue
5. Later Stage VC 25-Feb-2016 00.00 Completed Generating Revenue
4. Grant 01-Jan-2015 00.000 00.00 Completed Generating Revenue
3. Early Stage VC 04-Jun-2013 00000 00.00 00.000 Completed Generating Revenue
2. Early Stage VC 11-Feb-2013 $2.95M $2.95M Completed Generating Revenue
1. Grant 01-Jan-2010 $43.5K Completed Generating Revenue
To view MetGen’s complete valuation and funding history, request access »

MetGen Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
B shares 00,000 000.00 000.00 00 000.00 00.000
B shares 00,000 000.00 000.00 00 000.00 0.000
Ordinary 9,121 $67.82 $67.82 1x $67.82 4.49%
To view MetGen’s complete cap table history, request access »

MetGen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Producer of novel enzymatic products intended to enhance the pre-treatment of a variety of lingo-cellulosic biomasses in
Industrial Chemicals
Kaarina, Finland
33 As of 2021
00.000
00.00 0000-00-00
0000000000 0 00.000

00000000

uat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pa
00000 000000000 000 00000
Cardiff, United Kingdom
00.00 0000-00-00
000000&0

000 0000

sum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolor
000000000 000000000
Boulder, CO
00 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MetGen Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biocatalysts Corporate Backed or Acquired Cardiff, United Kingdom 000000&0
000 00000000000000 Venture Capital-Backed Boulder, CO 00 000.00 0000000000 0 000.00
You’re viewing 2 of 2 competitors. Get the full list »

MetGen Executive Team (6)

Name Title Board Seat Contact Info
Alex Michine Co-Founder and Chief Executive Officer
Petri Vahala Chief Financial Officer
Matti Heikkilä Chief Operating Officer
Alex Azhayev Ph.D Co-Founder and Chief Scientific Officer
Sami-Pekka Rantanen Director, Sales
You’re viewing 5 of 6 executive team members. Get the full list »

MetGen Board Members (8)

Name Representing Role Since
Gina Domanig Emerald Technology Ventures Board Member 000 0000
Joško Bobanović Ph.D Sofinnova Partners Board Member 000 0000
Martin Granholm MetGen Board Member 000 0000
Philipp Hasler Ph.D Emerald Technology Ventures Board Member 000 0000
Steven Govoni MetGen Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

MetGen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MetGen Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Innovestor Venture Capital Minority 000 0000 000000 0
Ecolab Corporation Minority 000 0000 000000 0
Innovestor Ventures Venture Capital Minority 000 0000 000000 0
Horizon 2020 Government 000 0000 000000 0
Emerald Technology Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »